Navigation Links
CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
Date:8/18/2011

the triptan class, which was first launched almost 20 years ago," remarked Thomas P. Mathers, Chief Executive Officer of CoLucid.  "Patient and physician feedback note that only a portion of migraine patients are adequately controlled on triptans, and patients would welcome a new product that could offer a rapid speed of onset, superior pain relief and/or a lack of cardiovascular side effects as compared to currently available products.  In addition, due to their vasoconstrictor activity, triptans are contraindicated in patients with cardiovascular disease.  Many neurologists and primary care physicians feel uncomfortable prescribing triptans because of their potential cardiovascular side effects.  Lasmiditan may address these unmet needs with its novel mechanism of action, and we look forward to the results of the Phase 3 trials to confirm its rapid speed of onset, superior pain relief and lack of cardiovascular side effects," said Mr. Mathers.

The Company is speaking with potential partners and is interacting with the FDA, and plans to advance lasmiditan into Phase 3 development.

About CoLucid Pharmaceuticals, Inc.

CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company's investors include Pappas Ventures, Domain Associates, Care Capital, Pearl Street Venture Funds and Triathlon Medical Ventures. The company's pipeline includes lasmiditan, a novel treatment for migraine headache, and a conjugated stigmine platform that has generated a series of preclinical candidates for the treatment of sleep/wake disorders, chronic pain, Alzheimer's disease and psychiatric disorders. For more information, please visit CoLucid at www.colucid.com.

Media Contact: Kathy Kelly CoLucid Pharmaceuticals, Inc., 919-806-4304, kkelly@colucid.co
'/>"/>

SOURCE CoLucid Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CoLucid Appoints Thomas P. Mathers as Chief Executive Officer
2. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
3. Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol
4. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
5. Access Pharmaceuticals Provides Second Quarter Update on MuGard Commercial Activities
6. Janssen Pharmaceuticals, Inc. Launches Online Tools on PrescribeResponsibly.com
7. Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results
8. Omthera Pharmaceuticals, Inc. Initiates Phase III ESPRIT Trial of Add-on Epanova™ to Statin Therapy in Patients with Hypertriglyceridemia
9. Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
10. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
11. Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... BALTIMORE , Oct. 17, 2014  Ameritox SM ... announced the appointment of Thomas Smith , M.D., ... lead a field-based team offering scientific resources for healthcare ... Smith has held leadership positions at a variety of ... will benefit both the pain and behavioral health sides ...
(Date:10/17/2014)... --  ndd Medical Technologies , a leader in innovative ... announced that its EasyOne Pro® is now being used ... 140,000 square foot, 44-bed hospital with many outpatient services. ... a large number of Native Americans from several tribes ... beyond. A portion of its funding comes from the ...
(Date:10/17/2014)... 2014  STAAR Surgical Company (NASDAQ: STAA ), ... systems for the eye, today announced that the Company will ... October 18, 7:00 a.m. CT at the American Academy of ... Dr. Erik Mertens , Medical Director ... Antwerp, Belgium , will present his first cases with ...
Breaking Medicine Technology:Ameritox Appoints New Chief Medical Officer 2EasyOne Pro Mobile Respiratory Testing from ndd Medical Technologies Chosen by Choctaw Nation 2STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting 2STAAR Surgical to Webcast Investor Presentations at American Academy of Ophthalmology's Annual Meeting 3
... Reportlinker.com announces that a new market ... Medical Imaging Markets: ... http://www.reportlinker.com/p0790439/Medical-Imaging-Markets-MRI-Magnetic-Resonance-Imaging-and-Ultrasound-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ... and potential world market for medical MRI ...
... SAN DIEGO, March 7, 2012   OncoSec Medical ... OncoSec Medical System (OMS) ElectroOncology therapies to treat ... Bhatia, Principal Investigator for the company,s Phase II ... a local Seattle news outlet, The Journal ...
Cached Medicine Technology:Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 2Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 3Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 4Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 5Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 6Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 7Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 8Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets 9OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 2OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 3OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper 4
(Date:10/20/2014)... California (PRWEB) October 20, 2014 Final Cut ... the release of the Citrus theme for FCPX filmmakers ... would use to describe the Citrus theme” Says Christina Austin, ... easy to look so professional.” , Citrus comes with all ... with the template are: four transitions for added style, a ...
(Date:10/20/2014)... October 20, 2014 Houston plastic surgeon ... the key elements of his innovative True Form ... plastic surgery residents and faculty at The University ... he, too, was once a medical student. Patronella, who ... private cosmetic plastic surgery practices in Texas, The ...
(Date:10/19/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... bamboo deckings . Moreover, the company has launched a ... available at deeply discounted rates. , As is ... the significance of online business nowadays. Thus, BambooIndustry.com pays ... workers are striving to deliver both value and efficiency ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
(Date:10/19/2014)... Stephen T. Greenberg, M.D., with offices in Woodbury, Southampton and ... as one of Long Island’s best cosmetic surgeons. In ... the best provider for Botox injections. Glisten, his Skin & ... best Laser Treatment center on Long Island.* , The voting ... the contest once per day, per IP address. , Stephen ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... Feb. 12 After Phil Cohen, president of ... interview last year, he signed on to do ... introduced those videos this week via PRN Funding,s ... formal launch of its YouTube Channel in place, ...
... Altmeyer brings extensive experience in neuroscience and oncology ... these therapeutic categories , , ROCKVILLE, ... America Pharmaceutical, Inc. (OAPI), a fast-growing health care ... in North America, has announced the appointment of ...
... Earns Milestone Payment of Additional $2.5 MillionCRANBURY, N.J., ... US: PTN) today announced it has received $4.1 ... its exclusive research collaboration and license agreement to ... receptors and a clinical trial sponsored research agreement. ...
... N.J., Feb. 12 DOR BioPharma, Inc. (OTC Bulletin ... it has signed a potential $30 million partnering agreement ... for the development and commercialization in North America of ... the agreement, Sigma - Tau will make a $6 ...
... Will Now Be Available to a Wider Medical Market through Nation,s ... ... 2009 -- Inviro Medical Devices, an industry leader in infection control ... of the nation,s largest and most respected GPOs, or group provider ...
... Montgomery law firm prevails on behalf of plaintiff in medical malpractice lawsuit ... hours of deliberations , ... Santa Rosa, Calif. (Lexis Nexis) February 12, ... the Santa Rosa law firm of Teal & Montgomery, scored a major ...
Cached Medicine News:Health News:PRN Funding Introduces the PRN Funding YouTube Channel 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 3Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 5Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 6Health News:Palatin Technologies Announces Receipt of $4.1 Million from AstraZeneca 2Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 2Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 3Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 4Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 5Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 6Health News:DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease 7Health News:Inviro Medical Devices Is Awarded a Three Year Contract with Leading GPO Novation 2Health News:Steve Teal, Santa Rosa Attorney, Obtains $850,000 for Client in Highest Hospital Negligence Verdict in Mendocino County 2
Sealing tape featuring 3M adhesive technology. Opaque and strong. Prevents photo-degradation....
Sealing tape featuring 3M adhesive technology. Compatible with DMSO. Good optical quality. Minimal autofluorescence....
Empore Sealing Tape Pads are ideal for covering a 96 well plate during storage or transfer to another work station. Not intended for use with auto-injectors....
... 'A' film is a quick and effective means ... plates and tubes. The compliant inner layer is ... smoothly. This minimizes the risk of aerosol formation ... cut for use with fewer than 96 wells, ...
Medicine Products: